Since 1988, the American Kidney Fund has been funding clinical research through Clinical Scientist in Nephrology fellowships with one goal: improving patient outcomes. Past CSN fellows have contributed mightily to this goal through their research.

Elaine Ku, M.D. (2013–14)

Awarded the American Kidney Fund-Amgen Clinical Scientist in Nephrology fellowship, Dr. Ku is a clinical and research fellow at University of California, San Francisco. Dr. Ku's research focused on the impact of blood pressure control during chronic kidney disease on outcomes after the development of end-stage renal disease.

Sagar Nigwekar, M.D. (2012–13)

Awarded the American Kidney Fund-Sanofi Clinical Scientist in Nephrology fellowship, Dr. Nigwekar is a clinical and research fellow at Massachusetts General Hospital. Dr. Nigwekar's research examined calciphylaxis and the role of vitamin D analogues and evaluation of serum biomarker.

Margaret Yu, M.D. (2012–14)

Awarded the American Kidney Fund-Sanofi Clinical Scientist in Nephrology fellowship, Dr. Yu is a nephrology fellow at the University of Washington. Dr. Yu's research examined the gender differences in chronic kidney disease prevalence, risk factors and progression in an outpatient diabetic population.

Katherine Lynch, M.D. (2012–14)

Awarded the American Kidney Fund-Amgen Clinical Scientist in Nephrology fellowship, Dr. Lynch is a nephrology fellow at Beth Israel Deaconess Medical Center. Dr. Lynch's research examined the clinical effectiveness of common interventions aimed at mitigating intradialytic hypotension.

Graham Abra, M.D. (2011–13)

As an American Kidney Fund-Amgen CSN fellow at Stanford School of Medicine, Dr. Abra's project focused on the design of an electronic health record-based intervention, using alerts for physicians, pharmacists and nurses for medications in need of adjustment in patients with hospital-acquired acute kidney injuries (AKI). Pre- and post-intervention response times to medication adjustment, adverse drug events, length of stay and risk-adjusted cost in patients with hospital acquired AKI were evaluated in order to learn process improvement through electronic health record order set design, multidisciplinary committee work and intervention analysis.

Ernest Mandel, M.D. (2011–13)

As an American Kidney Fund CSN fellow at Brigham and Women's Hospital and Harvard Medical School's Channing Laboratory, Dr. Mandel examined the role of diet in acid-base balance and the development and progression of chronic diseases, with a focus on developing preventive strategies to lessen their disease burden.

Jamie Green, M.D. (2010-2012)

As an American Kidney Fund-Genzyme CSN fellow from the University of Pittsburgh, Dr. Green's research examined the association of health literacy with clinical outcomes in hemodialysis patients. Her study assessed the association of health literacy with dialysis treatment adherence in patients receiving in-center hemodialysis. Dr. Green is currently a clinical investigator in the Nephrology Division at Geisinger Medical Center, a large integrated health system, in Danville, Pennsylvania.

Jenny Shen, M.D. (2010–12)

As an American Kidney Fund-Amgen CSN fellow at Stanford University, Dr. Shen's research, entitled “Risks and Benefits of Heparin Use in Maintenance Hemodialysis,” determined the associations among heparin dose and the risks of important clinical events. Her study also described patterns and correlated of heparin use in patients receiving maintenance hemodialysis at the facilities of a national provider of dialysis services. Dr. Shen is currently a postdoctoral fellow in nephrology in Stanford University's Division of Nephrology.

Delphine Tuot, M.D. (2010–11)

As an American Kidney Fund-Amgen CSN fellow at the University of California, San Francisco, Dr. Tuot's research determined whether patient awareness of CKD is associated with greater application of evidence-based medical regimens in a nationally representative sample. Additionally, her study sought to determine concordance between physician recognition and patient awareness of CKD in clinical settings with diverse patients in the San Francisco Bay area. Dr. Tuot is an assistant professor in the Division of Nephrology at the University of California, San Francisco.

Julie Wright-Nunes, M.D. (2009–11)

As an American Kidney Fund-Amgen CSN fellow at Vanderbilt University Medical Center, Dr. Wright's research, entitled “Facilitating Physician Delivered CKD Patient Education,” evaluated the impact of low-literacy materials used by nephrologists while delivering patient CKD education and care. Dr. Wright-Nunes is a clinical lecturer in the nephrology division of the University of Michigan's Department of Internal Medicine.

Nisha Bansal, M.D. (2008–10)

As an American Kidney Fund-Genzyme CSN fellow at the University of California, San Francisco, Dr. Bansal's research focused on the impact of CKD on the clinical presentation of coronary artery disease. Additionally, her study examined the role of CKD-specific risk factors and medication use on the presentation of coronary artery disease. Dr. Bansal is an assistant adjunct professor in the University of California, San Francisco's Department of Medicine.

Tamara Isakova, M.D. (2008–10)

As an American Kidney Fund-Amgen CSN fellow at Massachusetts General Hospital, Dr. Isakova's research, entitled “Postprandial Hypocalcemia in Secondary Hyperparathyroidism in Early Chronic Kidney Disease,” sought to enhance understanding of postprandial calcium and parathyroid metabolism and how to normalize these in early CKD. Dr. Isakova is an associate professor in medicine at the Northwestern University Feinberg School of Medicine and director of the Center for Translational Metabolism and Health.

Carmen Peralta, M.D. (2007–08)

As an American Kidney Fund-Amgen CSN fellow at the University of California, San Francisco, Dr. Peralta's research examined the roles that individual genetic ancestry and socioeconomic status play in chronic kidney disease, and how these factors impact the progression to end-stage renal disease. Dr. Peralta is an associate professor in residence at the University of California, San Francisco School of Medicine and co-founder and executive director of the Kidney Health Research Collaborative (KHRC).

Tammy Brady, M.D., M.H.S. (2006–08)

As an American Kidney Fund-Amgen CSN fellow from Johns Hopkins University, Dr. Brady investigated whether an automated computerized algorithm increased the recognition of elevated blood pressure in an urban primary pediatric clinic setting. Dr. Brady also worked to identify the modifiable risk factors associated with poor physician recognition of elevated blood pressure during well-child visits and determine the prevalence of hypertension in the stated population over a 12-month period. She was awarded Best Clinical Abstract at the American Society of Pediatric Nephrology annual meeting in 2007 for her work on this project. In July 2008, Dr. Brady joined the faculty of the Johns Hopkins University School of Medicine as assistant professor of pediatric nephrology. She is medical director of the Harriet Lane Kidney Center Pediatric Hypertension Program.

Orlando Gutierrez, M.D., M.M.Sc. (2006–08)

As an American Kidney Fund-Genzyme CSN fellow from Massachusetts General Hospital, Dr. Gutierrez examined novel connections between disorders of phosphorus metabolism and cardiovascular disease in patients with chronic kidney disease. In addition, he examined racial differences in phosphorus metabolism in healthy patients and in those with chronic kidney disease. Dr. Gutierrez was named the 2008 valedictorian of the Scholars in Clinical Science program at Harvard Medical School. Dr. Gutierrez is an associate professor at the University of Alabama at Birmingham's Schools of Medicine and Public Health and serves as Chair of Medical Affairs for the American Kidney Fund.

Jeffrey Fadrowski, M.D., M.H.S. (2005)

As an American Kidney Fund-Amgen CSN fellow at Johns Hopkins University, Dr. Fadrowski examined the type of vascular access in a cohort of pediatric hemodialysis patients and the relationship between the type of vascular access and the frequency of infection and hospitalization. In late 2005, Dr. Fadrowski joined the faculty of the Johns Hopkins University School of Medicine as an Assistant Professor of Pediatrics and was awarded NIH's K23 Mentored Patient-Oriented Research Career Development Award and the National Kidney Foundation's Young Investigator Grant Award.

Krista Lentine, M.D., M.S. (2004–05)

As an American Kidney Fund CSN fellow at Washington University School of Medicine in Missouri, Dr. Lentine explored registry data from the USRDS, OPTN and Medicare to investigate the risk, predictors and outcomes of cardiovascular disease events after kidney transplantation. During her CSN fellowship she completed a master's degree in clinical epidemiology from Stanford University. Since completing her CSN fellowship, she has earned a National Institutes of Health (NIH) Loan Repayment Award for Clinical Research and a five-year Career Development (K-series) Award from the NIH National Institute of Diabetes Digestive and Kidney Diseases for her active interests in the cardiovascular complications of kidney disease. Dr. Lentine is an associate professor of medicine with tenure at Saint Louis University, with joint appointments to the Internal Medicine/Nephrology Division and to the Saint Louis University Center for Outcomes Research.

Eric Taylor, M.D., M.Sc., FASN (2004–06)

As an American Kidney Fund-Genzyme CSN fellow at the Brigham and Women's Hospital of Massachusetts, Dr. Taylor evaluated novel risk factors for kidney stone formation. During his fellowship, he completed his master's degree in epidemiology from the Harvard School of Public Health. Dr. Taylor is an associate professor of medicine at Tufts University School of Medicine and is affiliated with Maine Nephrology Associates in Portland, Maine.

Yoshio Hall, M.D., M.S, (2003–05)

As an American Kidney Fund-Amgen CSN fellow at the University of California, San Francisco, Dr. Hall investigated processes and outcomes of care among Asian and Pacific Islander Americans with ESRD. During his fellowship, Dr. Hall completed the UCSF Advanced Training in Clinical Research Program and later received a master's degree in epidemiology from the University of Washington's School of Public Health. He is currently an associate professor in the Division of Nephrology and a core investigator at the Kidney Research Institute of the University of Washington.

Karen Smirnakis, M.D., Ph.D. (2003–05)

As an American Kidney Fund CSN fellow at Massachusetts General Hospital, Dr. Smirnakis' research interests focused on the prevention of end-stage renal disease by early diagnosis and treatment of diabetes mellitus. Her project examined postpartum screening for diabetes among women with a history of gestational diabetes. Dr. Smirnakis completed a Master of Public Health degree from the Harvard School of Public Health. She is currently working at Biogen Idec as senior medical director for safety and benefit risk.

Manjula Kurella Tamura, M.D., MPH (2002–04)

As an American Kidney Fund-Genzyme CSN fellow at the University of California, San Francisco, Dr. Kurella Tamura focused on the impact of chronic kidney disease in the elderly. Her research focused on cognitive function in elderly patients with advanced renal failure. Dr. Kurella Tamura received a Master of Public Health degree from University of California, Berkeley. Currently, she is an associate professor of medicine in the Division of Nephrology at Stanford University and the Veterans Affairs Palo Alto Geriatric Research and Education Clinical Center.

Jeffrey Rubel, M.D., MPH (2001–03) 

As an American Kidney Fund-Amgen CSN fellow at Brigham and Women's Hospital in Boston, Dr. Rubel evaluated the effectiveness of established guidelines for treating and preventing coronary artery disease, and the ability of health care providers to successfully implement these strategies. Dr. Rubel completed a Master of Public Health degree from the Harvard School of Public Health. He is now chief of nephrology at Northeast Health System near Boston. He is the medical director for the inpatient dialysis and apheresis programs there, and is the director of medical education for the hospital system.

Holly J. Kramer, M.D., M.P.H. (2000–02) 

As an American Kidney Fund CSN fellow at Massachusetts General Hospital, Dr. Kramer conducted what may be the first study to investigate the effects of hormone replacement therapy on morbidity and mortality in post-menopausal women with ESRD. During her CSN fellowship, Dr. Kramer completed a Master of Public Health degree from the Harvard School of Public Health. Dr. Kramer joined the faculty at Loyola Medical Center in 2002 with a joint appointment in the Department of Preventive Medicine and in the Department of Medicine, Division of Nephrology and Hypertension.

Preston S. Klassen, M.D., M.H.S. (2000–01)

As an American Kidney Fund CSN fellow at Duke University, Dr. Klassen conducted an in-depth study of the relationship between blood pressure and clinical outcomes in dialysis patients. Dr. Klassen had the unique opportunity to spend part of his fellowship at the Centers for Medicare and Medicaid Services in Baltimore. During his fellowship, Dr. Klassen completed the requirements for a Master of Health Science degree at the Duke University Clinical Research Training Program. Dr. Klassen was previously on the faculty of Duke University Medical Center and is now senior vice president of global management at Orexigen Therapeutics, Inc.

Liam Casserly, M.D., M.Sc. (1999–2001)

As an American Kidney Fund-Amgen CSN fellow at Boston Medical Center, Dr. Casserly conducted a study of hypertensive heart disease among ESRD patients and completed a Master of Science degree in epidemiology and biostatistics at Boston University's School of Public Health. He is now an academic nephrologist in Ireland.

Chi-Yuan Hsu, M.D., M.Sc. (1998-2000)

As an American Kidney Fund CSN fellow at Massachusetts General Hospital and later at the University of California, San Francisco, Dr. Hsu completed a study of the risk factors for chronic renal insufficiency. During his fellowship Dr. Hsu also earned an M.S. in epidemiology at the Harvard School of Public Health. Dr. Hsu became chief of the Division of Nephrology at UCSF in 2008 and he was promoted to professor in 2009.

Rulan S. Parekh, M.D., M.Sc. (1997–99)

As an American Kidney Fund-Amgen CSN fellow at the University of Michigan in Ann Arbor, Dr. Parekh conducted a study of cardiovascular mortality in children with ESRD. She also completed a Master of Public Health degree with a concentration in biostatistics and clinical research. Dr. Parekh is the staff nephrologist at The Hospital for Sick Children in Ontario, Canada. Dr. Parekh also served as a Trustee of the American Kidney Fund and was Chair of the CSN Committee.

Lynda Szczech, M.D., M.S.C.E. (1996–97)

As an American Kidney Fund CSN fellow at the University of Pennsylvania School of Medicine, Dr. Szczech studied the impact of post-transplant antibody therapy on kidney transplant survival. Dr. Szczech is currently associate professor of medicine at Duke University Medical Center in the Division of Nephrology.

Ravi Thadhani, M.D., MPH (1995–98)

As an American Kidney Fund-Amgen CSN fellow at Massachusetts General Hospital, Dr. Thadhani conducted research on pregnancy-related kidney disease and earned a Master in Public Health degree. Dr. Thadhani is chief of nephrology at Massachusetts General Hospital and a professor of medicine at Harvard Medical School.

David M. Kates, M.D., M.H.Sc. (1994–96):

As an American Kidney Fund CSN fellow at the University of Washington School of Medicine in Seattle, Dr. Kates studied cardiovascular disease in ESRD patients. Dr. Kates is the director of the renal program at Kelowna General Hospital, and the director of the regional transplant program. He is also on the faculty at the University of British Columbia Southern Medical Program.

Glenn M. Chertow, M.D., M.P.H. (1993–95)

As an American Kidney Fund-Amgen CSN fellow at Brigham and Women's Hospital in Boston, Dr. Chertow conducted research on nutrition and kidney disease and earned a master's degree in clinical epidemiology at the Harvard School of Public Health. Dr. Chertow is currently professor of medicine and chief of the Division of Nephrology at Stanford University School of Medicine. Prior to joining the faculty at Stanford, Dr. Chertow served with distinction on the faculties at Brigham and Women's Hospital and Harvard Medical School (1995-98) and the University of California, San Francisco (UCSF) (1998-2007). Dr. Chertow has established a successful career as a clinical investigator and continues to maintain a productive research program focused on improving care for patients with acute and chronic kidney disease. He was vice chair and member of two workgroups for the Kidney Disease Quality Outcomes Initiative (K/DOQI) and associate editor of the Journal of the American Society of Nephrology. Dr. Chertow serves on the American Kidney Fund's CSN Committee.

David A. Roth, M.D., M.S.C.E. (1992–94)

As an American Kidney Fund CSN fellow at the University of Pennsylvania, Dr. Roth conducted research on renal disease among African-Americans and earned a master's degree in clinical epidemiology. He subsequently served on the faculty at Temple University School of Medicine. Dr. Roth currently is group director of clinical development at GlaxoSmithKline Pharmaceuticals in Philadelphia.

Rebecca L. Hegeman, M.D., M.P.H. (1991–93)

As an American Kidney Fund CSN fellow, Dr. Hegeman researched renal failure in transplantation and completed classes required for a Master of Public Health. Dr. Hegeman is currently a clinical associate professor of internal medicine at the University of Iowa College of Medicine in Iowa City and interim director of the nephrology division. She was the medical director of the dialysis program at the University of Iowa from 2003 to 2007 and was the vice chair for clinical programs for the Department of Internal Medicine.

Gary C. Curhan, M.D., Sc.D. (1990–92)

As an American Kidney Fund CSN fellow, Dr. Curhan conducted studies focusing on kidney stones. His research has served as the foundation for the ground-breaking kidney stone research that Dr. Curhan currently pursues at Brigham and Women's Hospital in Boston. Dr. Curhan is a professor in the department of epidemiology at the Harvard T. H. Chan School of Public Health and a professor of medicine at Harvard Medical School and a member of the Channing Laboratory and the Renal Division of Brigham and Women's Hospital. Dr. Curhan is editor-in-chief of the Clinical Journal of the American Society of Nephrology.

Rhonda B. Rubin, M.D. (1989–91)

As an American Kidney Fund CSN fellow at Montefiore Medical Center in Bronx, New York, Dr. Rubin studied the impact and special needs of AIDS and HIV-infected patients in dialysis units. Dr. Rubin is an assistant professor of medicine at Albert Einstein College of Medicine in the Bronx. Dr. Rubin currently works at Westchester Health medical group in Valhalla, New York.

Stephen R. Smith, M.D., M.H.S. (1989–91)

As an American Kidney Fund CSN fellow at Duke University School of Medicine, Dr. Smith studied the effects of potassium chloride supplementation on blood pressure among elderly patients. Dr. Smith joined the Duke University faculty and became medical director of the kidney transplant program in 1993 and training program director for the nephrology fellowship in 2005.

Maria E. Ferris, M.D., M.P.H., Ph.D. (1989-1991)

As an American Kidney Fund CSN fellow at the University of California, San Diego, Dr. Ferris studied congenital renal and urinary tract conditions. Dr. Ferris is an associate professor of pediatrics and medicine at the University of North Carolina at Chapel Hill. She also founded the UNC Health Care Transition Program. Dr. Ferris is a pediatric nephrologist and epidemiologist who also directs the pediatric renal replacement therapy programs.